Long-term dual antiplatelet therapy and nuisance bleeding: impact on quality of life

Long-term dual antiplatelet therapy and nuisance bleeding: impact on quality of life

Long term dual antiplatelet therapy (LTDAPT), with ticagrelor 60 mg and low-dose aspirin, is indicated after acute coronary syndrome (ACS) for the secondary prevention of atherothrombotic events in high-risk patients with a history of ACS of at least 1 year. LTDAPT had a good tolerability and safet...

Full description

Bibliographic Details
Main Authors: Gennaro Ratti, Cinzia Monda, Federica Ratti, Marco Golino, Ludovica Fulgione, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro
Format: Article
Language:English
Published: PAGEPress Publications 2022-11-01
Series:Monaldi Archives for Chest Disease
Subjects:
Nuisance bleeding
dual antiplatelet therapy
quality of life
high ischemic risk
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/2437

Internet

https://www.monaldi-archives.org/index.php/macd/article/view/2437

Similar Items